123 related articles for article (PubMed ID: 33013119)
1. Brachytherapy for Oral Cavity Cancers in the Era of Intensity-Modulated Radiotherapy: Save it or Shelve it.
Alva RC; Koushik ASK; Sweta B; Janaki MG; Ponni TRA; Kumar M; Yuvaraj B; Revath T
Indian J Surg Oncol; 2020 Sep; 11(3):406-411. PubMed ID: 33013119
[TBL] [Abstract][Full Text] [Related]
2. [Dosimetry analysis of intensity-modulated and conformal radiation therapy for head and neck tumors].
Pesznyák C; Béla D; Takácsi-Nagy Z; Major T; Polgár C
Magy Onkol; 2015 Jun; 59(2):95-101. PubMed ID: 26035156
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
4. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
[TBL] [Abstract][Full Text] [Related]
5. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
[TBL] [Abstract][Full Text] [Related]
6. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
[TBL] [Abstract][Full Text] [Related]
9. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
Zhou J; Fei D; Wu Q
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
[TBL] [Abstract][Full Text] [Related]
10. Whole breast and excision cavity radiotherapy plan comparison: Conformal radiotherapy with sequential boost versus intensity-modulated radiation therapy with a simultaneously integrated boost.
Small K; Kelly C; Beldham-Collins R; Gebski V
J Med Radiat Sci; 2013 Mar; 60(1):16-24. PubMed ID: 26229603
[TBL] [Abstract][Full Text] [Related]
11. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
12. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
13. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
[TBL] [Abstract][Full Text] [Related]
14. Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx.
Murakami N; Yoshimoto S; Uematsu M; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Masui K; Yoshida K; Itami J
BJR Case Rep; 2020 Dec; 6(4):20200005. PubMed ID: 33299579
[TBL] [Abstract][Full Text] [Related]
15. Superiority of intensity-modulated radiotherapy over three-dimensional conformal radiotherapy combined with brachytherapy in nasopharyngeal carcinoma: a planning study.
Taheri-Kadkhoda Z; Pettersson N; Björk-Eriksson T; Johansson KA
Br J Radiol; 2008 May; 81(965):397-405. PubMed ID: 18250121
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of two treatment planning systems for spine SBRT.
Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
19. Per-oral interstitial brachytherapy catheter insertion for boost in case of recurrent tonsillar carcinoma: dosimetry and clinical outcome.
Murakami N; Yoshimoto S; Nakamura S; Uematsu M; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
BJR Case Rep; 2020 Mar; 6(1):20190059. PubMed ID: 32201608
[TBL] [Abstract][Full Text] [Related]
20. Volumetric-modulated arc radiotherapy for pancreatic malignancies: dosimetric comparison with sliding-window intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
Nabavizadeh N; Simeonova AO; Waller JG; Romer JL; Monaco DL; Elliott DA; Tanyi JA; Fuss M; Thomas CR; Holland JM
Med Dosim; 2014; 39(3):256-60. PubMed ID: 24857696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
